Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Benitec Biopharma Inc. (BNTC)

0.925   -0.235 (-20.26%) 07-02 19:27
Open: 1.06 Pre. Close: 1.16
High: 1.1305 Low: 0.9201
Volume: 611,019 Market Cap: 8(M)
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.13 - 1.14 1.14 - 1.15
Low: 0.9 - 0.91 0.91 - 0.92
Close: 0.91 - 0.92 0.92 - 0.93

Technical analysis

as of: 2022-07-01 4:20:31 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.84     One year: 2.45
Support: Support1: 0.74    Support2: 0.61
Resistance: Resistance1: 1.58    Resistance2: 2.09
Pivot: 1.02
Moving Average: MA(5): 1.29     MA(20): 1
MA(100): 1.68     MA(250): 2.7
MACD: MACD(12,26): 0     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 29.7     %D(3): 43.4
RSI: RSI(14): 44.3
52-week: High: 4.78  Low: 0.74
Average Vol(K): 3-Month: 2,267 (K)  10-Days: 13,490 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BNTC ] has closed above bottom band by 40.5%. Bollinger Bands are 82.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Headline News

Fri, 01 Jul 2022
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - InvestorPlace

Wed, 29 Jun 2022

Tue, 28 Jun 2022
Benitec Biopharma Inc (BNTC) is lower by 8.44% Tuesday In Premarket Trading - InvestorsObserver

Mon, 27 Jun 2022
Thinking about buying stock in Exela Technologies, Meta Materials, Tencent Music Entertainment, Revlon, o - Benzinga

Fri, 24 Jun 2022
US stocks higher at close of trade; Dow Jones Industrial Average up 2.68% By -

Fri, 24 Jun 2022
Healthcare Stocks on the Move Friday: BNTC, TCON, BHC, SOPH, TRDA, IMRX, MSPR, HOWL - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. -8 (M)
Shares Float 0 (M)
% Held by Insiders 8.17e+006 (%)
% Held by Institutions 5.38e+006 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -64000
EPS Est Next Qtl 0
EPS Est This Year -0.11
EPS Est Next Year -0.24
Book Value (p.s.) -2.68
Profit Margin (%) 0
Operating Margin (%) -61
Return on Assets (ttm) 803.5
Return on Equity (ttm) -73.3
Qtrly Rev. Growth 28000
Gross Profit (p.s.) 0
Sales Per Share -85.17
EBITDA (p.s.) -39024.4
Qtrly Earnings Growth -1.708e+007
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value -0.35
Price to Sales -0.02
Price to Cash Flow 0

Stock Dividends

Dividend 4840
Forward Dividend 5560
Dividend Yield 523243%
Dividend Pay Date 2019-11-17
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.